It is definitely not pure capitalism in play here: The federal health department fixes the price for both brands and generics – the latter has to be priced at least 20% below the brand product for consumers to be reimbursed by their insurance company. Every few years, the government revisits the price difference, and typically adjusts the price downwards in a move to lower healthcare costs.